Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults

This study has been completed.
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00123968
First received: July 22, 2005
Last updated: July 21, 2014
Last verified: July 2014